Denise ScotsKnight - Elanco Animal Independent Director
| 5EA Stock | EUR 12.76 0.30 2.41% |
Insider
Denise ScotsKnight is Independent Director of Elanco Animal Health since 2019.
| Age | 59 |
| Tenure | 5 years |
| Phone | 877 352 6261 |
| Web | https://www.elanco.com |
Elanco Animal Management Efficiency
The company has return on total asset (ROA) of 0.0189 % which means that it generated a profit of $0.0189 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0104) %, meaning that it generated substantial loss on money invested by shareholders. Elanco Animal's management efficiency ratios could be used to measure how well Elanco Animal manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Justin Scarpulla | Identiv | 50 | |
| MBA MBA | Superior Plus Corp | 70 | |
| James Hoffman | Reliance Steel Aluminum | 64 | |
| Min Tang | Origin Agritech | 61 | |
| David Bullock | Origin Agritech | 49 | |
| Arthur Ajemyan | Reliance Steel Aluminum | 47 | |
| CCLP CMA | Superior Plus Corp | 62 | |
| Karla Lewis | Reliance Steel Aluminum | 57 | |
| Jeffrey Durham | Reliance Steel Aluminum | 60 | |
| Yasheng Yang | Origin Agritech | 51 | |
| Geoffery Merszei | Origin Agritech | 68 | |
| James Kang | Origin Agritech | 54 | |
| Michael Trimble | Origin Agritech | 56 | |
| Harry Kanwar | Superior Plus Corp | N/A | |
| Manfred Mueller | Identiv | 53 | |
| Gengchen Han | Origin Agritech | 58 | |
| Fei Wang | Origin Agritech | 40 | |
| FCA FCA | Superior Plus Corp | 68 | |
| Amir Khoshniyati | Identiv | N/A | |
| Vandy Lupton | Reliance Steel Aluminum | N/A | |
| Sean Mollins | Reliance Steel Aluminum | 44 | |
Management Performance
| Return On Equity | -0.0104 | |||
| Return On Asset | 0.0189 |
Elanco Animal Health Leadership Team
Elected by the shareholders, the Elanco Animal's board of directors comprises two types of representatives: Elanco Animal inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Elanco. The board's role is to monitor Elanco Animal's management team and ensure that shareholders' interests are well served. Elanco Animal's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Elanco Animal's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Joshua Smiley, Independent Director | ||
| Chris Keeley, VP Officer | ||
| Carl McMillian, Independent Director | ||
| Sarena Lin, Executive Vice President, Global Marketing, Corporate Strategy and Transformation | ||
| Jeffrey Simmons, President, Chief Executive Officer, Director | ||
| Denise ScotsKnight, Independent Director | ||
| David Kinard, Executive Vice President of Human Resources | ||
| David Urbanek, Executive Vice President - Manufacturing, Quality | ||
| Aaron Schacht, Executive Vice President - Innovation, Regulatory, Business Development | ||
| R Hoover, Independent Chairman of the Board | ||
| Larbi Lier, VP Asia | ||
| Kirk McDonald, Independent Director | ||
| James Meer, Chief Accounting Officer, Vice President | ||
| Art Garcia, Independent Director | ||
| Kapila Anand, Independent Director | ||
| Michael Harrington, Independent Director | ||
| Todd Young, Chief Financial Officer, Executive Vice President | ||
| David Ricks, Independent Director | ||
| Marcela Kirberger, Gen VP | ||
| Shawn McKee, Sr Animal | ||
| Deborah Kochevar, Independent Director | ||
| Lawrence Kurzius, Independent Director | ||
| Ramiro Cabral, Executive Vice President - Elanco International | ||
| Aarti Shah, Independent Director | ||
| John Bilbrey, Independent Director | ||
| MichaelBryant Hicks, Executive Vice President General Counsel, Corporate Secretary |
Elanco Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Elanco Animal a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0104 | |||
| Return On Asset | 0.0189 | |||
| Profit Margin | (0.02) % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 10.92 B | |||
| Shares Outstanding | 474.2 M | |||
| Shares Owned By Insiders | 0.27 % | |||
| Shares Owned By Institutions | 99.73 % | |||
| Price To Earning | 98.33 X | |||
| Price To Book | 0.89 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Elanco Stock
When determining whether Elanco Animal Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Elanco Animal's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Elanco Animal Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Elanco Animal Health Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Elanco Animal Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.